DECNUPAZ Trademark

Trademark Overview

On Friday, June 11, 2021, a trademark application was filed for DECNUPAZ with the United States Patent and Trademark Office. The USPTO has given the DECNUPAZ trademark a serial number of 90769164. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, June 3, 2024. This trademark is owned by ImmunoGen, Inc.. The DECNUPAZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions

General Information

Serial Number90769164
Word MarkDECNUPAZ
Filing DateFriday, June 11, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, June 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements

Goods and ServicesPharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunoGen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameImmunoGen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Tuesday, June 15, 2021NEW APPLICATION ENTERED
Tuesday, August 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 2, 2022ASSIGNED TO EXAMINER
Tuesday, March 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 28, 2022SOU TEAS EXTENSION RECEIVED
Monday, November 28, 2022SOU EXTENSION 1 FILED
Monday, November 28, 2022SOU EXTENSION 1 GRANTED
Wednesday, November 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 2, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 2, 2023SOU EXTENSION 2 FILED
Friday, June 2, 2023SOU EXTENSION 2 GRANTED
Tuesday, June 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 30, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, November 27, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 27, 2023SOU EXTENSION 3 FILED
Monday, November 27, 2023SOU EXTENSION 3 GRANTED
Wednesday, November 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 3, 2024SOU EXTENSION 4 GRANTED
Monday, June 3, 2024SOU EXTENSION 4 FILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 14, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 14, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 14, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 14, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 21, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

decnupaz preparations pharmaceuticals pharmaceutical treatment namely human disorders conditions oncological cancer